{"id":29678,"date":"2018-10-02T10:22:32","date_gmt":"2018-10-02T18:22:32","guid":{"rendered":"http:\/\/cannabiscultivatornews.com\/home\/index.php\/2018\/10\/02\/cbd-drugmaker-gw-pharmaceuticals-poised-to-raise-300-million\/"},"modified":"2018-10-02T12:45:43","modified_gmt":"2018-10-02T20:45:43","slug":"cbd-drugmaker-gw-pharmaceuticals-poised-to-raise-300-million","status":"publish","type":"post","link":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/2018\/10\/02\/cbd-drugmaker-gw-pharmaceuticals-poised-to-raise-300-million\/","title":{"rendered":"CBD drugmaker GW Pharmaceuticals poised to raise $300 million"},"content":{"rendered":"<\/p>\n<p>GW Pharmaceuticals is setting out to sell $300 million worth of U.S. depository shares. The London-based company\u2019s announcement\u00a0comes on the heels of\u00a0the U.S. Drug Enforcement Administration\u2019s move\u00a0to take some cannabidiol products off the most restrictive class of controlled substances. That change will allow Epidiolex \u2013 a CBD drug manufactured by GW Pharmaceuticals to treat rare [\u2026]<\/p>\n<p><a rel=\"nofollow\" href=\"https:\/\/mjbizdaily.com\/cbd-drugmaker-gw-pharmaceuticals-poised-to-raise-300-million-with-stock-offering\/\">CBD drugmaker GW Pharmaceuticals poised to raise $300 million<\/a> is a post from: <a href=\"http:\/\/mjbizdaily.com\">Marijuana Business Daily: Financial, Legal &amp; Cannabusiness news for cannabis entrepreneurs<\/a><\/p>\n<p>&#013;<br \/>\n&#013;<br \/>\nRead More: <a href=\"https:\/\/mjbizdaily.com\/cbd-drugmaker-gw-pharmaceuticals-poised-to-raise-300-million-with-stock-offering\/\" target=\"_blank\">CBD drugmaker GW Pharmaceuticals poised to raise 0 million<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>GW Pharmaceuticals is setting out to sell $300 million worth of U.S. depository shares. The London-based company\u2019s announcement\u00a0comes on the heels of\u00a0the U.S. Drug Enforcement Administration\u2019s move\u00a0to take some cannabidiol products off the most restrictive class of controlled substances. That change will allow Epidiolex \u2013 a CBD drug manufactured by<span class=\"more-link\"><a href=\"https:\/\/cannabiscultivatornews.com\/home\/index.php\/2018\/10\/02\/cbd-drugmaker-gw-pharmaceuticals-poised-to-raise-300-million\/\">Continue Reading<\/a><\/span><\/p>\n","protected":false},"author":198,"featured_media":0,"comment_status":"false","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[4,490,1393,2786,32,19,195],"tags":[],"_links":{"self":[{"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/posts\/29678"}],"collection":[{"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/users\/198"}],"replies":[{"embeddable":true,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/comments?post=29678"}],"version-history":[{"count":1,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/posts\/29678\/revisions"}],"predecessor-version":[{"id":29679,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/posts\/29678\/revisions\/29679"}],"wp:attachment":[{"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/media?parent=29678"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/categories?post=29678"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/tags?post=29678"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}